Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2018 Filed Jan 2, 2018 21:30 UTC |
Krakauer Andrew ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 2,178 | $0.00 Strike: $248.82 | $0.00 |
DisclosureSEC source: 0000096943-18-000004 · wf-form4_151492862165721.xml · derivative · entry 2 Krakauer Andrew A · CIK 0001302168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,178 Underlying: Common Stock · 2,178 shares Expires 2028-01-01 F2 · shares: Stock Option Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Option vests on July 1, 2018. Read SEC document |
| January 01, 2018 Filed Jan 2, 2018 21:30 UTC |
Krakauer Andrew ADirector
|
GrantCommon Stock | 113 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-18-000004 · wf-form4_151492862165721.xml · nonDerivative · entry 1 Krakauer Andrew A · CIK 0001302168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113 F1 · shares: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest on July 1, 2018. Read SEC document |
| December 22, 2017 Filed Feb 13, 2018 02:45 UTC |
Leyden James JVP, General Counsel, Secretary
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-18-000014 · wf-form5_151848992990636.xml · nonDerivative · entry 1 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142 Read SEC document |
| December 11, 2017 Filed Feb 13, 2018 02:49 UTC |
Hicks Cameron PVice President, Global HR
|
GiftCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-18-000016 · wf-form5_151849016133220.xml · nonDerivative · entry 1 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,639.614 Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:41 UTC |
SMITH BENSONDirector · Chairman & CEO
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0000096943-17-000141 · wf-form4_151252087384953.xml · derivative · entry 5 SMITH BENSON · CIK 0001211667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2018-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:41 UTC |
SMITH BENSONDirector · Chairman & CEO
|
SaleCommon Stock | 21 | $258.26 | $5,423.46 |
DisclosureSEC source: 0000096943-17-000141 · wf-form4_151252087384953.xml · nonDerivative · entry 4 SMITH BENSON · CIK 0001211667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,634 Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:41 UTC |
SMITH BENSONDirector · Chairman & CEO
|
SaleCommon Stock | 1,879 | $258.12 | $485,007.48 |
DisclosureSEC source: 0000096943-17-000141 · wf-form4_151252087384953.xml · nonDerivative · entry 3 SMITH BENSON · CIK 0001211667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,655 Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:41 UTC |
SMITH BENSONDirector · Chairman & CEO
|
SaleCommon Stock | 100 | $257.69 | $25,769.10 |
DisclosureSEC source: 0000096943-17-000141 · wf-form4_151252087384953.xml · nonDerivative · entry 2 SMITH BENSON · CIK 0001211667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,534 Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:41 UTC |
SMITH BENSONDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 2,000 | $56.25 | $112,500.00 |
DisclosureSEC source: 0000096943-17-000141 · wf-form4_151252087384953.xml · nonDerivative · entry 1 SMITH BENSON · CIK 0001211667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 23:17 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000139 · wf-form4_151242941238783.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 23:17 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $265.32 | $53,064.00 |
DisclosureSEC source: 0000096943-17-000139 · wf-form4_151242941238783.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 23:17 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000139 · wf-form4_151242941238783.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $237.18 | $47,436.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $241.88 | $48,376.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $211.75 | $42,350.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $208.41 | $41,682.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 21:28 UTC |
Boylan KarenVice President, Global RA/QA
|
Tax withholdingCommon Stock | 95 | $210.10 | $19,959.50 |
DisclosureSEC source: 0000096943-17-000095 · wf-form4_150153652623060.xml · nonDerivative · entry 1 Boylan Karen · CIK 0001627013 · Vice President, Global RA/QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $208.10 | $41,620.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 21, 2017 Filed Jun 22, 2017 22:02 UTC |
HAGGERTY GRETCHEN RDirector
|
PurchaseCommon Stock | 1,000 | $203.82 | $203,818.00 |
DisclosureSEC source: 0000096943-17-000088 · wf-form4_149816893233158.xml · nonDerivative · entry 1 HAGGERTY GRETCHEN R · CIK 0001236161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,760 F1 · price: This transaction was executed in multiple trades at prices ranging from $203.720 to $203.888. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:16 UTC |
RANDLE STUART ADirector
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 2,500 | $42.75 Strike: $42.75 | $106,875.00 |
DisclosureSEC source: 0000096943-17-000086 · wf-form4_149695656367824.xml · derivative · entry 5 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2019-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:16 UTC |
RANDLE STUART ADirector
|
SaleCommon Stock | 2,300 | $205.67 | $473,047.90 |
DisclosureSEC source: 0000096943-17-000086 · wf-form4_149695656367824.xml · nonDerivative · entry 4 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,032 Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:16 UTC |
RANDLE STUART ADirector
|
SaleCommon Stock | 100 | $205.67 | $20,566.50 |
DisclosureSEC source: 0000096943-17-000086 · wf-form4_149695656367824.xml · nonDerivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,332 Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:16 UTC |
RANDLE STUART ADirector
|
SaleCommon Stock | 100 | $205.59 | $20,559.00 |
DisclosureSEC source: 0000096943-17-000086 · wf-form4_149695656367824.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 21:16 UTC |
RANDLE STUART ADirector
|
Exercise / conversionCommon Stock | 2,500 | $42.75 | $106,875.00 |
DisclosureSEC source: 0000096943-17-000086 · wf-form4_149695656367824.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $199.93 | $39,986.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · derivative · entry 7 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $192.04 | $38,408.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 5 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 5,000 | $56.75 Strike: $56.75 | $283,750.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · derivative · entry 6 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 2,400 | $193.67 | $464,817.60 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 2,600 | $193.57 | $503,284.60 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,280 Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 5,000 | $56.75 | $283,750.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:24 UTC |
RANDLE STUART ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $194.40 | $0.00 |
DisclosureSEC source: 0000096943-17-000071 · wf-form4_149445503889635.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410 Underlying: Common Stock · 1,410 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:24 UTC |
RANDLE STUART ADirector
|
GrantCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-17-000071 · wf-form4_149445503889635.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,032 F1 · shares: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest on November 9, 2017. Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:21 UTC |
PACKER RICHARD ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 2,820 | $0.00 Strike: $194.40 | $0.00 |
DisclosureSEC source: 0000096943-17-000069 · wf-form4_149445487662484.xml · derivative · entry 2 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,820 Underlying: Common Stock · 2,820 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:21 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-17-000069 · wf-form4_149445487662484.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,593.808 F1 · shares: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest on November 9, 2017. Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:17 UTC |
Klasko Stephen K. M.D.Director
|
GrantStock Option / (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $194.40 | $0.00 |
DisclosureSEC source: 0000096943-17-000067 · wf-form4_149445466541581.xml · derivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410 Underlying: Common Stock · 1,410 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:17 UTC |
Klasko Stephen K. M.D.Director
|
GrantCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-17-000067 · wf-form4_149445466541581.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · shares: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest on November 9, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.